In CHC patients, markers of serum and hepatocyte iron overload associate with genetic polymorphisms in IFNλ3 gene region, well known predictors of both spontaneous and IFN-treatment-induced HCV clearance [18] as well as HFE gene mutations [19]. The gene discussed is IFNL3; the disease is cryohydrocytosis.